NORWALK, Conn., Nov. 20, 2014 /PRNewswire/ -- UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers, provides special coverage on recent advances in neuroimaging.
Neuroimaging serves as a useful adjunct to clinical assessment, and advances in neuroimaging are critical to understanding the workings of the human brain, detecting diseases before their clinical signs appear, and developing targeted drug therapies.
Coverage of recent advances in neuroimaging on Neurology Times includes the following:
- New Imaging Spots Inflammation in Brain Disorders: A new radioactive "tracer" can be used to observe inflammation-related changes in the brain. The tool could be useful in making the diagnosis of Alzheimer disease in humans and monitoring this disorder and others affected by neuroinflammation.
- Idiopathic Primary Generalized Epilepsies: Benign? Study authors did a careful 2-year follow-up of cognitive trajectory and volumetric MRI analysis of patients with juvenile myoclonic epilepsy. Patients appear to have modest cognitive defects and imaging abnormalities early on that are unlikely to be associated with anti-epileptic therapy—a clear departure from traditional teaching.
- MRI Predicts MS Risk, Even Without Symptoms: Determining who is at risk for multiple sclerosis remains difficult, and symptoms may take time to develop even in patients who already have some destroyed myelin. Risk assessment might be useful for strategies that delay or prevent disease progression.
- MRI May Advance Parkinson Gene Therapy: These therapies for Parkinson disease appeared to be safe in clinical trials, but up until now, they have not produced promising efficacy results.
About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Americas which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections. Headquartered in New York, UBM Americas brings together UBM's healthcare business, UBM Medica US; UBM Tech's technology communities, live events and custom services; UBM Canon's advanced design and manufacturing event, online and print brands; UBM Connect New York's catering, cruise shipping, contact-center management, and fine, specialty and custom chemical communities; and UBM Mexico's concrete, construction and hospitality services shows. For more information, visit www.UBMMedicaUS.com.
About UBM plc
UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.
For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.
Jason J. Golden
Content Marketing Manager
SOURCE UBM Medica US